APA (7th ed.) Citation

CE, C., Z, C., K, W., I, O., AT, L., TN, C., . . . H, A. (2025). Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma. European urology, 88(5), 472. https://doi.org/10.1016/j.eururo.2025.04.008

Chicago Style (17th ed.) Citation

CE, Chu, et al. "Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma." European Urology 88, no. 5 (2025): 472. https://doi.org/10.1016/j.eururo.2025.04.008.

MLA (9th ed.) Citation

CE, Chu, et al. "Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma." European Urology, vol. 88, no. 5, 2025, p. 472, https://doi.org/10.1016/j.eururo.2025.04.008.